ATE425157T1 - Chemokin rezeptor bindenden heterozyklische verbindungen - Google Patents

Chemokin rezeptor bindenden heterozyklische verbindungen

Info

Publication number
ATE425157T1
ATE425157T1 AT01971574T AT01971574T ATE425157T1 AT E425157 T1 ATE425157 T1 AT E425157T1 AT 01971574 T AT01971574 T AT 01971574T AT 01971574 T AT01971574 T AT 01971574T AT E425157 T1 ATE425157 T1 AT E425157T1
Authority
AT
Austria
Prior art keywords
receptor binding
heterocyclic compounds
chemokine receptor
binding heterocyclic
ccr5
Prior art date
Application number
AT01971574T
Other languages
English (en)
Inventor
Gary Bridger
Renato Skerlj
Al Kaller
Curtis Harwig
David Bogucki
Trevor Wilson
Jason Crawford
Ernest Mceachern
Bem Atsma
Siqiao Nan
Yuanxi Zhou
Dominique Schols
Christopher Smith
Fluri Rosaria Di
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of ATE425157T1 publication Critical patent/ATE425157T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
AT01971574T 2000-09-15 2001-09-17 Chemokin rezeptor bindenden heterozyklische verbindungen ATE425157T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23289100P 2000-09-15 2000-09-15
US23451000P 2000-09-22 2000-09-22

Publications (1)

Publication Number Publication Date
ATE425157T1 true ATE425157T1 (de) 2009-03-15

Family

ID=26926422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01971574T ATE425157T1 (de) 2000-09-15 2001-09-17 Chemokin rezeptor bindenden heterozyklische verbindungen

Country Status (22)

Country Link
US (3) US6864265B2 (de)
EP (1) EP1317445B1 (de)
JP (1) JP2004508422A (de)
KR (1) KR20030029998A (de)
CN (1) CN1457339A (de)
AT (1) ATE425157T1 (de)
AU (2) AU9156901A (de)
BR (1) BR0113930A (de)
CA (1) CA2419224A1 (de)
DE (1) DE60137944D1 (de)
ES (1) ES2325909T3 (de)
HK (1) HK1052011A1 (de)
HU (1) HUP0301093A2 (de)
IL (1) IL154227A0 (de)
MX (1) MXPA03002326A (de)
NO (1) NO20031179D0 (de)
NZ (1) NZ524420A (de)
PL (1) PL360932A1 (de)
RU (1) RU2289581C2 (de)
SG (1) SG126007A1 (de)
TR (1) TR200300322T2 (de)
WO (1) WO2002022600A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122175T2 (de) 2000-09-15 2007-07-05 Anormed Inc., Langley Chemokinrezeptor bindende heterozyklische Verbindungen
ATE420873T1 (de) * 2000-09-15 2009-01-15 Anormed Inc Chemokin rezeptor bindenden heterozyklische verbindungen
ES2325909T3 (es) * 2000-09-15 2009-09-24 Anormed Inc. Compuestos heterociclicos que se unen a los receptores de quimioquinas.
US7169750B2 (en) 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
LT2371361T (lt) 2001-07-31 2019-09-10 Genzyme Corporation Pirmtakų/kamieninių ląstelių suaktyvinimo būdai
HUP0402458A2 (hu) * 2001-12-21 2005-07-28 Anormed Inc. Fokozott hatékonyságú kemokin receptor kötő heterociklusos vegyületek
US7354932B2 (en) * 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
KR100863667B1 (ko) * 2002-09-11 2008-10-15 가부시끼가이샤 구레하 아민 화합물 및 그 용도
US7504422B2 (en) 2003-04-02 2009-03-17 Taigen Biotechnology Co. Ltd. Polyamine compounds
DE602004024871D1 (de) 2003-04-02 2010-02-11 Taigen Biotechnology Co Ltd Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
US7291631B2 (en) 2003-04-11 2007-11-06 Genzyme Corporation CXCR4 chemokine receptor binding compounds
JP4710606B2 (ja) * 2003-04-18 2011-06-29 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
US7501518B2 (en) 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
NZ542850A (en) 2003-04-22 2007-12-21 Anormed Inc Chemokine receptor binding heterocyclic compounds with enhanced efficacy
KR20060054410A (ko) * 2003-08-01 2006-05-22 제네랩스 테크놀로지스, 인코포레이티드 플라비비리다에에 대한 2고리 이미다졸 유도체
US7498346B2 (en) 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
CA2548393A1 (en) 2003-12-11 2005-06-30 Anormed Inc. Chemokine receptor binding compounds
CN1950343B (zh) * 2004-03-10 2013-06-19 株式会社吴羽 胺系碱性化合物及其用途
CN1930127B (zh) * 2004-03-15 2012-11-21 阿诺麦德股份有限公司 用于合成cxcr4拮抗剂的方法
EP1732905A1 (de) * 2004-03-31 2006-12-20 Lexicon Genetics Incorporated 2-aminomethylthiazol-5-carbonsäureamide als proteinkinasemodulatoren
WO2006020891A2 (en) * 2004-08-13 2006-02-23 Anormed Inc. Chemokine combinations to mobilize progenitor/stem cells
PE20060646A1 (es) * 2004-08-16 2006-08-04 Smithkline Beecham Corp Derivados de bencimidazol como moduladores de la actividad de quimioquinas
EP1786388B2 (de) * 2004-08-19 2018-11-28 Colgate-Palmolive Company Verbesserte ölfreisetzung durch strukturierte emulgator zubereitungen
JP5135795B2 (ja) * 2004-08-27 2013-02-06 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
JP2008511669A (ja) * 2004-09-02 2008-04-17 スミスクライン ビーチャム コーポレーション 化合物
EP1793825A4 (de) * 2004-09-24 2009-12-09 Smithkline Beecham Corp Chemische verbindungen
TW200619206A (en) * 2004-09-29 2006-06-16 Anormed Inc Chemokine-binding heterocyclic compound salts, and methods of use thereof
EP1844042A1 (de) * 2005-01-14 2007-10-17 Genelabs Technologies, Inc. Indolderivate zur behandlung viraler infektionen
US7501526B2 (en) 2005-01-20 2009-03-10 Taigen Biotechnology Synthesis of polyamine compounds
WO2006138350A2 (en) 2005-06-15 2006-12-28 Anormed Inc. Chemokine receptor binding compounds
EP1904501A2 (de) * 2005-07-11 2008-04-02 Smithkline Beecham Corporation Chemische verbindungen
US20070043012A1 (en) 2005-08-19 2007-02-22 Bridger Gary J Methods to enhance chemotherapy
PL1961744T3 (pl) 2005-11-18 2013-09-30 Ono Pharmaceutical Co Związek zawierający grupę zasadową oraz jego zastosowanie
WO2007115231A2 (en) * 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
WO2007115232A2 (en) 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
WO2007132846A1 (ja) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. 保護されていてもよい酸性基を含有する化合物およびその用途
CN101495115A (zh) * 2006-08-02 2009-07-29 健赞股份有限公司 组合治疗
US20100178271A1 (en) * 2006-08-07 2010-07-15 Genzyme Corporation Combination Therapy
US20110105477A1 (en) * 2007-09-14 2011-05-05 The Regents Of The University Of Michigan Compositions and methods relating to hiv protease inhibition
PL2300459T3 (pl) * 2008-07-02 2013-10-31 Hoffmann La Roche Nowe fenylopirazynony jako inhibitory kinazy
JP2012502048A (ja) * 2008-09-08 2012-01-26 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
WO2012075362A2 (en) 2010-12-03 2012-06-07 Emory University Chemokine cxcr4 receptor modulators and used related thereto
CN102603683B (zh) * 2012-02-10 2014-04-09 山东大学 一种呋喃类化合物及其制备方法与应用
CN104478795A (zh) * 2014-11-24 2015-04-01 苏州乔纳森新材料科技有限公司 一种2-氯烟醛的制备方法
EP3302710A4 (de) 2015-06-03 2019-02-20 The University of Queensland Mobilisierungsmittel und verwendung davon
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
MA49357A (fr) * 2015-10-06 2020-04-22 Proteostasis Therapeutics Inc Composés, compositions et méthodes permettant de moduler le cftr
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
WO2017106332A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3389634B1 (de) 2015-12-14 2021-10-06 X4 Pharmaceuticals, Inc. Verfahren zur behandlung von krebs
CA3009176A1 (en) 2015-12-22 2017-06-29 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
JP2019510785A (ja) 2016-04-08 2019-04-18 エックス４ ファーマシューティカルズ， インコーポレイテッド 癌を処置する方法
US10759796B2 (en) 2016-06-21 2020-09-01 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
US11332470B2 (en) 2016-06-21 2022-05-17 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
EP3471726A4 (de) 2016-06-21 2019-10-09 X4 Pharmaceuticals, Inc. Cxcr4-inhibitoren und verwendungen davon
WO2018073248A1 (en) 2016-10-17 2018-04-26 Icm (Institut Du Cerveau Et De La Moelle Épinière) Prognosis of demyelinating diseases patients and treatment thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
GB201910608D0 (en) * 2019-07-24 2019-09-04 Enterprise Therapeutics Ltd Compounds
CN112110853A (zh) * 2020-09-23 2020-12-22 海南梵圣生物科技有限公司 一种合成3-羟基-2-吡啶甲酸及其衍生物的方法
CN116375650A (zh) * 2022-12-30 2023-07-04 浙江美诺华药物化学有限公司 一种替戈拉生中间体的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021409A (en) 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
US6001826A (en) 1989-12-21 1999-12-14 Anormed, Inc. Chemical compounds
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
GB9511357D0 (en) * 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
CN1264373A (zh) 1997-07-16 2000-08-23 西巴特殊化学品控股有限公司 多缩水甘油基螺环化合物及其在环氧树脂中的应用
AU2654399A (en) * 1998-02-02 1999-08-16 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
JPH11269146A (ja) * 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
JP2002535256A (ja) 1999-01-25 2002-10-22 スミスクライン・ビーチャム・コーポレイション 化合物および方法
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
JP2003524620A (ja) * 1999-03-24 2003-08-19 アノーメッド インコーポレイティド ケモカインレセプター結合複素環化合物
ATE420873T1 (de) * 2000-09-15 2009-01-15 Anormed Inc Chemokin rezeptor bindenden heterozyklische verbindungen
ES2325909T3 (es) * 2000-09-15 2009-09-24 Anormed Inc. Compuestos heterociclicos que se unen a los receptores de quimioquinas.

Also Published As

Publication number Publication date
EP1317445B1 (de) 2009-03-11
WO2002022600A2 (en) 2002-03-21
US7396840B2 (en) 2008-07-08
MXPA03002326A (es) 2003-06-06
BR0113930A (pt) 2003-06-24
HUP0301093A2 (hu) 2003-09-29
HK1052011A1 (zh) 2003-08-29
WO2002022600A3 (en) 2002-05-10
NZ524420A (en) 2005-04-29
US20060128750A1 (en) 2006-06-15
US6864265B2 (en) 2005-03-08
NO20031179L (no) 2003-03-14
JP2004508422A (ja) 2004-03-18
SG126007A1 (en) 2006-10-30
TR200300322T2 (tr) 2003-09-22
NO20031179D0 (no) 2003-03-14
AU2001291569B2 (en) 2007-07-26
AU9156901A (en) 2002-03-26
KR20030029998A (ko) 2003-04-16
CN1457339A (zh) 2003-11-19
DE60137944D1 (de) 2009-04-23
US20040220207A1 (en) 2004-11-04
IL154227A0 (en) 2003-07-31
US7084155B2 (en) 2006-08-01
ES2325909T3 (es) 2009-09-24
EP1317445A2 (de) 2003-06-11
US20030018046A1 (en) 2003-01-23
PL360932A1 (en) 2004-09-20
CA2419224A1 (en) 2002-03-21
RU2289581C2 (ru) 2006-12-20

Similar Documents

Publication Publication Date Title
DE60137944D1 (de) Chemokin rezeptor bindenden heterozyklische verbindungen
DE60122175D1 (de) Chemokin rezeptor bindenden heterozyklischen verbindungen
GB0115862D0 (en) Compounds
UA87473C2 (en) Muscarinic acetycholine receptor antagonists
DE60039446D1 (de) Cyclische aminverbindung als ccr5 antagonist
ECSP066486A (es) Antagonistas de receptores de acetilcolina muscarínicos ii
ATE327988T1 (de) Chemokine rezeptor bindende heterozyklische verbindungen
EP1613613A4 (de) Cxcr4-chemokinrezeptor-bindende verbindungen
UY28598A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
NO20060775L (no) Muskarine acetylkolinreseptorantagonister
NO20060777L (no) Muskarine acetylkolinreseptorantagonister
EP1244452A4 (de) Urotensin-ii rezeptorantagonisten
BRPI0412679A (pt) antagonistas de receptor muscarìnico de acetilcolina
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
TW200531686A (en) Pharmaceutical compositions
TR200200357T2 (tr) Yeni integrin reseptör antagonistleri
ATE418542T1 (de) Als ccr5-antagonisten verwendbare aryloxim- piperazine
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
DE69526738D1 (de) Endothelin-rezeptor-antagonisten
TR200103774U (tr) Pamuk balyalarının bağlanmasında kullanılan kenetli tel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties